243 related articles for article (PubMed ID: 15985451)
1. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis.
Kariagina A; Zonis S; Afkhami M; Romanenko D; Chesnokova V
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E857-63. PubMed ID: 15985451
[TBL] [Abstract][Full Text] [Related]
2. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Chesnokova V; Melmed S
Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary cytokine network.
Kariagina A; Romanenko D; Ren SG; Chesnokova V
Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders.
Mitsukawa K; Mombereau C; Lötscher E; Uzunov DP; van der Putten H; Flor PJ; Cryan JF
Neuropsychopharmacology; 2006 Jun; 31(6):1112-22. PubMed ID: 16237391
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis.
Ware CB; Kariagina A; Zonis S; Alon D; Chesnokova V
FEBS Lett; 2005 Aug; 579(20):4465-9. PubMed ID: 16081071
[TBL] [Abstract][Full Text] [Related]
7. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
Chesnokova V; Kariagina A; Melmed S
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
[TBL] [Abstract][Full Text] [Related]
9. Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response.
Langlais D; Couture C; Balsalobre A; Drouin J
PLoS Genet; 2008 Oct; 4(10):e1000224. PubMed ID: 18927629
[TBL] [Abstract][Full Text] [Related]
10. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
[TBL] [Abstract][Full Text] [Related]
11. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
Heydendael W; Jacobson L
Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
[TBL] [Abstract][Full Text] [Related]
12. Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice.
Tajima T; Ma XM; Bornstein SR; Aguilera G
Endocrinology; 1999 Jul; 140(7):3354-62. PubMed ID: 10385433
[TBL] [Abstract][Full Text] [Related]
13. The effects of high fat diet on the basal activity of the hypothalamus-pituitary-adrenal axis in mice.
Auvinen HE; Romijn JA; Biermasz NR; Pijl H; Havekes LM; Smit JW; Rensen PC; Pereira AM
J Endocrinol; 2012 Aug; 214(2):191-7. PubMed ID: 22619233
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
17. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
Schmidt MV; Sterlemann V; Wagner K; Niederleitner B; Ganea K; Liebl C; Deussing JM; Berger S; Schütz G; Holsboer F; Müller MB
Endocrinology; 2009 Jun; 150(6):2709-16. PubMed ID: 19213843
[TBL] [Abstract][Full Text] [Related]
18. Modifications of glucocorticoid receptors mRNA expression in the hypothalamic-pituitary-adrenal axis in response to early-life stress in female Japanese quail.
Zimmer C; Spencer KA
J Neuroendocrinol; 2014 Dec; 26(12):853-60. PubMed ID: 25303060
[TBL] [Abstract][Full Text] [Related]
19. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
Chesnokova V; Auernhammer CJ; Melmed S
Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
